Antigen binding proteins and assays
AssigneeGlaxosmithkline Biologicals SA
InventorsNathalie NORAIS, Silvia ROSSI PACCANI, Simona RONDINI
Life of this patent
Estimating the term…
Loading patent…
AssigneeGlaxosmithkline Biologicals SA
InventorsNathalie NORAIS, Silvia ROSSI PACCANI, Simona RONDINI
Estimating the term…
The present invention relates to the field of antigen binding proteins and the use of such antigen binding proteins in an assay. More particularly, it relates to antigen binding proteins which bind to an epitope of Protein E and antigen binding proteins which bind to an epitope of PilA. The present invention also relates to assays (particularly in vitro assays) for assessing binding to Protein E and/or PilA and the potency of vaccines containing Protein E and/or PilA. In particular the invention relates to in vitro relative potency assays used in the release of a vaccine to the public.
1-16. (canceled)
An antigen binding protein which binds to Protein E at one or more of amino acid residues within I41 to Y49 (e.g. SEQ ID NO:
An antigen binding protein comprising:
Dependencies are inferred from the claim text.